Finally, after all this years, the product is being withdrawn from the market. The question is, how many people have suffered side effects from it, is AstraZeneca trying to cover it up - Could that be the real reason they are suddenly withdrawing their injection now? It definitely is ...
AstraZeneca today announced that the company has decided to withdraw the anticoagulant ExantaTM (melagatran / ximelagatran) from the market and terminate its development. AstraZeneca estimates that approximately 400 patients are currently being prescribed the drug for short-term prevention of venous ...
However, AstraZeneca filed an administrative lawsuit against this, resulting in the current price being maintained until next February, but the price is likely to drop by 30 percent from March next year as previously scheduled. Who will benefit from Forxiga withdrawal? With AstraZeneca’s decision ...